CGS 21595

structure given in first source; inhibits the formation of 5-hydroxyeicosatetraenoic acid and leukotriene B4; rapidly metabolized to CGS 19213

Also Known As:

CGS-21595; 1,2-Naphthalenediol, 4-(cyclohexylmethylamino)-, diacetate (ester)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Peripheral Nervous System Diseases (PNS Diseases) 03/01/1992 - "A peripheral neuropathy consisting predominantly of myelin destruction in the spinal nerve roots and sciatic nerves in male rats treated with greater than or equal to 150 mg/kg CGS 21595 and in female rats treated with greater than or equal to 50 mg/kg CGS 21595 for 13 weeks. "